Paper Details

  1. Home
  2. Paper Details

A rare but serious complication of ticagrelor therapy: a case report.

Author: AriotiManfredi, De CesareNicoletta Bianca, LaudisaMaria Luisa, SirianniGiovanni

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Ticagrelor is a drug that helps prevent blood clots, which is important for patients with heart problems. The most common side effects are shortness of breath and a slow heart rate, but the slow heart rate is usually not serious.
Paper Details　
Original Abstract of the Article :
Ticagrelor is a widely used P2Y12 inhibitor and represents a fundamental therapeutic agent in acute coronary syndrome treatment and selected post-percutaneous coronary intervention (PCI) cases. Dyspnoea and bradycardia are the most common side effects but the latter has been reported to be of trivia...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649444/

データ提供：米国国立医学図書館（NLM）

Ticagrelor: A Potent Drug with a Rare but Serious Complication

This study delves into the world of cardiovascular medicine, focusing on ticagrelor, a widely used antiplatelet medication. The researchers present a case report of a patient experiencing dyspnea and bradycardia following ticagrelor therapy. This case report highlights the potential for rare but serious adverse events associated with this drug, underscoring the importance of vigilant monitoring and prompt intervention.

Ticagrelor: A Double-Edged Sword

This case report serves as a cautionary tale, highlighting the potential for serious complications even with commonly used medications. The development of dyspnea and bradycardia following ticagrelor therapy underscores the importance of ongoing research into the potential risks and benefits of this drug. Healthcare providers must remain vigilant, closely monitoring patients for any signs of adverse effects, and be prepared to intervene promptly.

Navigating the Desert of Cardiovascular Treatment: Balancing Efficacy and Safety

This study reminds us that even the most effective medications can have unintended consequences. It emphasizes the importance of understanding the potential risks and benefits of any treatment, and the need for ongoing vigilance in monitoring patients for any adverse effects. Healthcare providers and patients must work together to ensure that the benefits of treatment outweigh the potential risks, optimizing cardiovascular care and preserving overall health.

Dr. Camel's Conclusion

This case report, like a hidden scorpion in the desert, reminds us that even with the most potent medications, unforeseen dangers can lurk. While ticagrelor offers hope for patients with cardiovascular conditions, it's crucial to be aware of potential complications and to seek prompt treatment if they arise.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-04-18
Further Info :

Pubmed ID

33204945

DOI: Digital Object Identifier

PMC7649444

Related Literature

Article Analysis
・Side Effects of prasugrel
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.